Sinopharm Group (OTCMKTS:SHTDY) and Acreage (OTCMKTS:ACRDF) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.
Analyst Ratings
This is a breakdown of current ratings and price targets for Sinopharm Group and Acreage, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Sinopharm Group | 0 | 0 | 0 | 0 | N/A |
Acreage | 0 | 0 | 1 | 0 | 3.00 |
Acreage has a consensus target price of $6.00, indicating a potential upside of 133.05%. Given Acreage's higher possible upside, analysts clearly believe Acreage is more favorable than Sinopharm Group.
Earnings & Valuation
This table compares Sinopharm Group and Acreage's gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Sinopharm Group | N/A | N/A | N/A | N/A | N/A |
Acreage | N/A | N/A | N/A | N/A | N/A |
Profitability
This table compares Sinopharm Group and Acreage's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Sinopharm Group | N/A | N/A | N/A |
Acreage | N/A | N/A | N/A |
Summary
Acreage beats Sinopharm Group on 2 of the 2 factors compared between the two stocks.